🇪🇸 Spain · EU Public Tender
Suministro de medicamentos biosimilares Ustekinumab, Ranibizumab y Eculizumab para el Sector de Huesca.
🏛️ Gerencia Sector Sanitario de Huesca · 📍 Huesca
100 K€
Estimated value
31 August 2026
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Deadline | 31 August 2026 |
| Awarded to | AMGEN,S.A. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.